Department of Microbiology, University of Washington School of Medicine, Seattle, United States
Manuel Pazos
Centre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle, United Kingdom
Adrian J Verster
Department of Genome Sciences, University of Washington, Seattle, United States
Matthew C Radey
Department of Microbiology, University of Washington School of Medicine, Seattle, United States
Hemantha D Kulasekara
Department of Microbiology, University of Washington School of Medicine, Seattle, United States
Mary Q Ching
Department of Microbiology, University of Washington School of Medicine, Seattle, United States
Nathan P Bullen
Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada
Diane Bryant
Experimental Systems Group, Advanced Light Source, Berkeley, United States
Young Ah Goo
Northwestern Proteomics Core Facility, Northwestern University, Chicago, United States
Michael G Surette
Michael DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Canada; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Canada; Department of Medicine, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Canada
Elhanan Borenstein
Department of Genome Sciences, University of Washington, Seattle, United States; Department of Computer Science and Engineering, University of Washington, Seattle, United States; Santa Fe Institute, Santa Fe, United States
Waldemar Vollmer
Centre for Bacterial Cell Biology, Institute for Cell and Molecular Biosciences, Newcastle University, Newcastle, United Kingdom
Department of Microbiology, University of Washington School of Medicine, Seattle, United States; Howard Hughes Medical Institute, University of Washington School of Medicine, Seattle, United States
The Firmicutes are a phylum of bacteria that dominate numerous polymicrobial habitats of importance to human health and industry. Although these communities are often densely colonized, a broadly distributed contact-dependent mechanism of interbacterial antagonism utilized by Firmicutes has not been elucidated. Here we show that proteins belonging to the LXG polymorphic toxin family present in Streptococcus intermedius mediate cell contact- and Esx secretion pathway-dependent growth inhibition of diverse Firmicute species. The structure of one such toxin revealed a previously unobserved protein fold that we demonstrate directs the degradation of a uniquely bacterial molecule required for cell wall biosynthesis, lipid II. Consistent with our functional data linking LXG toxins to interbacterial interactions in S. intermedius, we show that LXG genes are prevalent in the human gut microbiome, a polymicrobial community dominated by Firmicutes. We speculate that interbacterial antagonism mediated by LXG toxins plays a critical role in shaping Firmicute-rich bacterial communities.